This statistic displays the market share of probiotics and gastrointestinal drugs sold in Spain between October 2017 and September 2018, based on revenue and by pharmaceutical company. Over the period of time under consideration, Italfarmaco was the leading provider of these pharmaceutical products in Spain, accounting for almost 18 percent of total units sold within this segment.
Revenue market share of probiotics and gastrointestinal drugs sold in Spain between October 2017 and September 2018, by pharmaceutical company
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
IM Farmacias. (December 4, 2018). Revenue market share of probiotics and gastrointestinal drugs sold in Spain between October 2017 and September 2018, by pharmaceutical company [Graph]. In Statista. Retrieved December 27, 2024, from https://www.statista.com/statistics/963137/revenue-market-share-of-probiotics-and-gastrointestinal-sold-in-spain-by-company/
IM Farmacias. "Revenue market share of probiotics and gastrointestinal drugs sold in Spain between October 2017 and September 2018, by pharmaceutical company." Chart. December 4, 2018. Statista. Accessed December 27, 2024. https://www.statista.com/statistics/963137/revenue-market-share-of-probiotics-and-gastrointestinal-sold-in-spain-by-company/
IM Farmacias. (2018). Revenue market share of probiotics and gastrointestinal drugs sold in Spain between October 2017 and September 2018, by pharmaceutical company. Statista. Statista Inc.. Accessed: December 27, 2024. https://www.statista.com/statistics/963137/revenue-market-share-of-probiotics-and-gastrointestinal-sold-in-spain-by-company/
IM Farmacias. "Revenue Market Share of Probiotics and Gastrointestinal Drugs Sold in Spain between October 2017 and September 2018, by Pharmaceutical Company." Statista, Statista Inc., 4 Dec 2018, https://www.statista.com/statistics/963137/revenue-market-share-of-probiotics-and-gastrointestinal-sold-in-spain-by-company/
IM Farmacias, Revenue market share of probiotics and gastrointestinal drugs sold in Spain between October 2017 and September 2018, by pharmaceutical company Statista, https://www.statista.com/statistics/963137/revenue-market-share-of-probiotics-and-gastrointestinal-sold-in-spain-by-company/ (last visited December 27, 2024)
Revenue market share of probiotics and gastrointestinal drugs sold in Spain between October 2017 and September 2018, by pharmaceutical company [Graph], IM Farmacias, December 4, 2018. [Online]. Available: https://www.statista.com/statistics/963137/revenue-market-share-of-probiotics-and-gastrointestinal-sold-in-spain-by-company/
